{"id":"W4379283389","doi":"10.1200/jco.2023.41.16_suppl.3110","title":"First-in-human (FIH) phase I dose escalation study (part A) of the first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) roginolisib in patients with advanced cancer and dose confirmation in uveal melanoma (part B).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melanoma; Internal medicine; Cancer; Hematology; Cohort; Dosing; Response Evaluation Criteria in Solid Tumors; Oncology; Gastroenterology; Pharmacology; Phases of clinical research; Toxicity; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008396427,0.0009923778,0.0008955713,0.0003155593,0.0003253086,0.0006009414,0.0005240131,0.000830204,0.005011233],"category_scores_gemma":[0.0004929086,0.0003942646,0.0006446578,0.0002805959,0.0006672856,0.0005355339,0.0003289272,0.001878175,0.000890715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009425535,"about_ca_system_score_gemma":0.001207397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009484189,"about_ca_topic_score_gemma":0.002264506,"domain_scores_codex":[0.9997466,0.0001023265,0.000008044223,0.00004061993,0.00002478871,0.00007760517],"domain_scores_gemma":[0.9996233,0.00004537625,0.00007092176,0.00004719386,0.00001974123,0.000193429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4890023,0.1264412,0.02366726,0.0008387055,0.0009782405,0.0006149961,0.0005863711,0.004872291,0.1518963,0.0007900447,0.01294246,0.1873699],"study_design_scores_gemma":[0.2435739,0.6891754,0.0426354,0.00003810883,0.0003204402,0.000616644,0.00008538046,0.001333806,0.01243627,0.0004812914,0.009267228,0.00003618596],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913366,0.000768795,0.000571166,0.0002458169,0.00004030797,0.002831376,0.002078431,0.00007073615,0.002056738],"genre_scores_gemma":[0.9846043,0.0006657722,0.002204603,0.0006631576,0.00007986855,0.002664467,0.003476859,0.00003262364,0.005608406],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005011233,"threshold_uncertainty_score":0.01676422,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05513052242782712,"score_gpt":0.3994851417478971,"score_spread":0.34435461932007,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}